This Drug is the Best and Worst News for Cystic Fibrosis
This CF drug is good news for health... and also awful news financially.

This Drug is the Best and Worst News for Cystic Fibrosis

Not long ago, Vertex Pharmaceuticals scored a big one for their investors—the European Commission has approved the use of ORKAMBI® (lumacaftor/ivacaftor), for the treatment of cystic fibrosis. This breakthrough treatment will be used…

Continue Reading This Drug is the Best and Worst News for Cystic Fibrosis